Download Learnerz IAS app from the Play Store now! Download



Medicine Patent Pool (MPP) UPSC NOTE


  • The MPP is a United Nations-backed group that works towards increasing access to life-saving medicines for low- and middle-income countries. 

  • It facilitates the development of affordable generic versions of patented medicines.

  • The MPP has signed sub-licence agreements with India-based companies Eugia, Hetero, and Dr. Reddy’s Laboratories, as well as the Indonesian firm BrightGene. 

  • These agreements allow these companies to produce generic versions of the cancer drug Nilotinib, originally patented by Novartis.


  • The sub-licence agreements aim to make cancer drugs more accessible and affordable for patients. 

  • By allowing generic manufacturers to produce Nilotinib, the cost of the medication can be significantly reduced, making it more accessible to patients in low- and middle-income countries.

  • Nilotinib is used in the treatment of chronic myeloid leukaemia, a type of blood cancer. 

  • The availability of generic versions of this drug allows more patients to access the treatment they need for this life-threatening condition.


  • The selected manufacturers in India and other middle-income countries have been granted the rights to produce generic versions of Nilotinib

  • This promotes competition in the market, leading to lower prices and increased availability of the medication.

  • The sub-licence agreements are non-exclusive, allowing multiple manufacturers to produce and supply generic versions of Nilotinib. 

  • This ensures a diverse supply of the medication, promoting availability and affordability in a wider range of territories.


  • The supply of generic Nilotinib by the licensed manufacturers is subject to local regulatory authorizations in the respective countries. 

  • This ensures that the generic versions meet quality and safety standards before being made available to patients.

  • The availability of generic Nilotinib through the MPP's efforts provides an affordable treatment option for individuals diagnosed with chronic myeloid leukaemia in low- and middle-income countries. 

  • This helps address the financial barriers that often limit access to life-saving medicines.


  • The licence agreement between the MPP and Novartis includes the opportunity to develop and supply generic versions of Nilotinib in seven middle-income countries. 

  • This expands the reach of affordable cancer treatment options beyond low-income countries, benefiting a wider population.



Amritsar,1,April 2024,301,Art & Culture,1,August 2023,251,Courses,7,Daily Current Affairs,48,December 2023,189,Disaster Management,2,Environment and Ecology,54,February 2024,228,Foundation Course,1,GDP,1,GEMS Club,1,GEMS Plus,1,Geography,67,Govt Schemes,2,GST,1,History,2,Home,3,IAS Booklist,1,Important News,71,Indian Economy,46,Indian History,2,Indian Polity,56,International Organisation,12,International Relations,58,Invasive Plant,1,January 2024,240,July 2023,281,June 2022,6,June 2023,268,March 2024,238,May 2022,17,May 2024,213,Mentorship,2,November 2023,169,October 2023,203,Places in News,2,Science & Technology,66,September 2023,205,UPSC CSE,111,
Learnerz IAS | Concept oriented UPSC Classes in Malayalam: Medicine Patent Pool (MPP) UPSC NOTE
Medicine Patent Pool (MPP) UPSC NOTE
Learnerz IAS | Concept oriented UPSC Classes in Malayalam
Loaded All Posts Not found any posts VIEW ALL Readmore Reply Cancel reply Delete By Home PAGES POSTS View All RECOMMENDED FOR YOU LABEL ARCHIVE SEARCH ALL POSTS Not found any post match with your request Back Home Sunday Monday Tuesday Wednesday Thursday Friday Saturday Sun Mon Tue Wed Thu Fri Sat January February March April May June July August September October November December Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec just now 1 minute ago $$1$$ minutes ago 1 hour ago $$1$$ hours ago Yesterday $$1$$ days ago $$1$$ weeks ago more than 5 weeks ago Followers Follow THIS PREMIUM CONTENT IS LOCKED STEP 1: Share to a social network STEP 2: Click the link on your social network Copy All Code Select All Code All codes were copied to your clipboard Can not copy the codes / texts, please press [CTRL]+[C] (or CMD+C with Mac) to copy Table of Content